Pharmaceutical & Life Sciences News

Roche Chairman Predicts Swathe of China Drug Approvals (1)

Nov. 6, 2018, 2:32 PM

Swiss pharmaceutical giant Roche Holding AG expects as many as five of its drugs will be approved by China in the next two years as the government accelerates the roll-out of new medicines to meet demand from a rapidly aging population.

“China is taking the political decision to spend more for health care,” Chairman Christoph Franz said in an interview at the China International Import Expo in Shanghai on Nov. 6. “Chinese consumers are sophisticated, and you are expecting that if you have a health issue you’ll get the best care. The government is receptive to this, and this gives...

To read the full article log in. To learn more about a subscription click here.